Our efforts on behalf of patients and caregivers, access principles, commitment to diversity in clinical trials, and Patient Assistance Programs.
Novartis Commitment to Patients & Caregivers
Only by working together and delivering on the four pillars of our Commitment, can we improve outcomes for patients and change the practice of medicine.
Every year, our medications reach nearly 800 million patients worldwide, but many more people still lack access to essential treatments and healthcare.
Diversity in Clinical Trials
At Novartis, we believe that diversity in clinical trials is essential to determine the relevance of data across the populations that our products are intended to treat.
Novartis believes that medicines should be available to all who need them. We have a variety of programs to help support patients and make it easier for them to afford and access their medications.